Home › Evolocumab 140 mg/ml

Evolocumab 140 mg/ml

2 products in 1 country, cheapest first.

Qatar (2)

About evolocumab

PCSK9 cholesterol-lowering antibody

Used for

Lowers LDL cholesterol in adults and children aged 10 years or older with inherited high cholesterol.
Reduces cardiovascular risk in adults with established heart or blood-vessel disease.

Usual adult dose

140 mg injected under the skin every 2 weeks, or 420 mg monthly, alongside cholesterol-lowering treatment.

Usual dose in children

For inherited high cholesterol from age 10: 140 mg under the skin every 2 weeks, or 420 mg monthly.

Common side effects

Runny nose, sore throat, or flu-like symptoms
Back pain
Injection-site reactions
Allergic reactions, rarely severe

Important warnings

Rare serious allergic reactions can occur.
May be used with other cholesterol medicines; LDL levels should be monitored.
The monthly dose requires three injections given consecutively or an approved dosing device.

Pregnancy

Human pregnancy data are limited; use during pregnancy requires weighing potential benefits and risks.

Breastfeeding

It is not known whether evolocumab passes into breast milk; discuss potential benefits and risks.

AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.

Evolocumab 140 mg/ml in Qatar

Repatha
Evolocumab 140 mg/ml · Sterile single-use solution for subcutaneous injection in pre-filled pen (SureClick pen) · 1’s pre-filled pen

1095 QAR
Repatha
Evolocumab 140 mg/ml · Sterile single-use solution for subcutaneous injection in pre-filled pen (SureClick pen) · 2’s pre-filled pen

2188 QAR